ANXA4 and urinary bladder carcinoma: Studies show that ANXA4 is overexpressed in bladder cancer tissues, especially in the luminal subtype [42,43], and its increased expression promotes cell cycle progression and inhibits apoptosis, correlating with poorer prognosis [44].